<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE nitf SYSTEM "http://www.nitf.org/IPTC/NITF/3.3/specification/dtd/nitf-3-3.dtd">
<nitf change.date="June 10, 2005" change.time="19:30" version="-//IPTC//DTD NITF 3.3//EN">
  <head>
    <title>Science Education Needed</title>
    <meta content="LTR004454" name="slug"/>
    <meta content="3" name="publication_day_of_month"/>
    <meta content="10" name="publication_month"/>
    <meta content="2000" name="publication_year"/>
    <meta content="Tuesday" name="publication_day_of_week"/>
    <meta content="Science Desk" name="dsk"/>
    <meta content="3" name="print_page_number"/>
    <meta content="F" name="print_section"/>
    <meta content="5" name="print_column"/>
    <meta content="Science; Opinion" name="online_sections"/>
    <docdata>
      <doc-id id-string="1235793"/>
      <doc.copyright holder="The New York Times" year="2000"/>
      <identified-content>
        <classifier class="indexing_service" type="descriptor">Bendectin (Drug)</classifier>
        <classifier class="indexing_service" type="descriptor">Pregnancy and Obstetrics</classifier>
        <classifier class="indexing_service" type="descriptor">Birth Defects</classifier>
        <person class="indexing_service">Gindi, Renee</person>
        <classifier class="online_producer" type="types_of_material">Letter</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Science</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion/Opinion</classifier>
        <classifier class="online_producer" type="general_descriptor">Birth Defects</classifier>
        <classifier class="online_producer" type="general_descriptor">Drugs (Pharmaceuticals)</classifier>
        <classifier class="online_producer" type="general_descriptor">Pregnancy and Obstetrics</classifier>
        <classifier class="online_producer" type="general_descriptor">Diseases and Conditions</classifier>
        <classifier class="online_producer" type="general_descriptor">Medicine and Health</classifier>
      </identified-content>
    </docdata>
    <pubdata date.publication="20001003T000000" ex-ref="http://query.nytimes.com/gst/fullpage.html?res=9904E3DE103DF930A35753C1A9669C8B63" item-length="193" name="The New York Times" unit-of-measure="word"/>
  </head>
  <body>
    <body.head>
      <hedline>
        <hl1>Science Education Needed</hl1>
      </hedline>
      <abstract>
        <p>Renee Gindi letter on Sept 26 article on comeback of controversial drug Bendectin</p>
      </abstract>
    </body.head>
    <body.content>
      <block class="lead_paragraph">
        <p>To the Editor:</p>
        <p>The recent article on Bendectin (''Controversial Drug Makes a Comeback,'' Sept. 26) touches on the larger issue of scientific evidence in the public eye.</p>
      </block>
      <block class="full_text">
        <p>To the Editor:</p>
        <p>The recent article on Bendectin (''Controversial Drug Makes a Comeback,'' Sept. 26) touches on the larger issue of scientific evidence in the public eye.</p>
        <p>Some medical products never proven to be toxic, like Bendectin and silicone breast implants, have involved billions in settlements. We trust our peers to respond on the basis of scientific evidence, and yet huge suits against Bendectin were won without any scientific proof before being overturned on appeal.</p>
        <p>The American public doesn't need more public advocates to take our cases to court. We need a better scientific education to understand the implications of drug research and an ability to make health decisions outside the influence of junk science and ''conventional wisdom.''</p>
        <p>RENEE GINDI  Berkeley, Calif.</p>
      </block>
    </body.content>
  </body>
</nitf>
